$0.4537
0.001620.36%
At close: -
$0.4658
0.012.66%
After Hours: 7:04 AM EDT
Turnstone Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Turnstone Biologics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.74 | $-0.86 | 14.0 % |
Jun 2024 | 2024-08-14 | $-0.92 | $-0.84 | -9.52 % |
Mar 2024 | 2024-05-13 | $-0.85 | $-0.78 | -8.97 % |
Dec 2023 | 2024-03-21 | $-0.73 | $-0.86 | 15.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Turnstone Biologics (TSBX) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.74, which beat the estimate of $-0.86.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.